SCM
Sio Capital Management Portfolio holdings
AUM
$604M
Turnover
53.26%
1-Year Est. Return
96.57%
This Fund
S&P 500
This Quarter
Est. Return
+1.97%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$332M
AUM Growth
+$18M
(+5.7%)
Cap. Flow
+$32.5M
Cap. Flow
% of AUM
9.81%
Top 10 Holdings %
Top 10 Hldgs %
51.98%
Holding
84
New
23
Increased
13
Reduced
10
Closed
14
Avg Time Held Equity + Options
0.8
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MSAC
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
|
+$22.6M |
| 2 |
Cencora
COR
|
+$12M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$10.2M |
| 4 |
Cardinal Health
CAH
|
+$9.51M |
| 5 |
Merck
MRK
|
+$8.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SOLY
Soliton, Inc.
SOLY
|
+$16.8M |
| 2 |
HCA Healthcare
HCA
|
+$13.7M |
| 3 |
Universal Health Services
UHS
|
+$12.8M |
| 4 |
HealthEquity
HQY
|
+$4.76M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$4.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 82.8% |
| 2 | Financials | 7.24% |
| 3 | Miscellaneous | 6.49% |
| 4 | Consumer Staples | 2.98% |
| 5 | Industrials | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Cigna
CI
$76.2B
| $27.9M | 8.4% |
121,330
-16,894
| -12% | -$3.59M |
2020 Q3
5 quarters
|
|
|
MSAC
2
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $22.6M | 6.81% |
+2,323,000
| New | +$22.6M |
2021 Q4
0 quarters
|
|
3
Curis
CRIS
$1.45M
| $18.4M | 5.55% |
9,667
+2,382
| +33% | +$5.66M |
2020 Q2
6 quarters
|
|
|
4
Merck
MRK
$364B
| $17.9M | 5.4% |
233,661
+108,661
| +87% | +$8.65M |
2021 Q3
1 quarter
|
|
|
5
Cardinal Health
CAH
$56.4B
| $17.3M | 5.2% |
335,271
+193,848
| +137% | +$9.51M |
2020 Q2
6 quarters
|
|
6
SPDR Gold Trust
GLD
$139B
| $15.4M | 4.63% |
89,890
-12,663
| -12% | -$2.13M |
2020 Q1
7 quarters
|
|
7
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.91B
| $14.4M | 4.34% |
261,377
+36,658
| +16% | +$1.91M |
2021 Q3
1 quarter
|
|
8
McKesson
MCK
$113B
| $14.2M | 4.28% |
57,056
+13,259
| +30% | +$2.91M |
2019 Q3
9 quarters
|
|
|
9
Cencora
COR
$63.7B
| $12.9M | 3.9% |
+97,440
| New | +$12M |
2021 Q4
0 quarters
|
|
10
United Therapeutics
UTHR
$23.3B
| $11.5M | 3.47% |
53,193
-5,953
| -10% | -$1.17M |
2018 Q4
12 quarters
|
|
11
Centene
CNC
$34.2B
| $10.4M | 3.12% |
125,779
-53,453
| -30% | -$3.92M |
2021 Q1
3 quarters
|
|
12
Herbalife
HLF
$1.48B
| $9.88M | 2.98% |
241,437
+25,425
| +12% | +$1.06M |
2020 Q3
5 quarters
|
|
|
13
Ionis Pharmaceuticals
IONS
$7.13B
| $9.82M | 2.96% |
+322,566
| New | +$10.2M |
2021 Q4
0 quarters
|
|
14
Aveanna Healthcare
AVAH
$2.65B
| $7.09M | 2.14% |
958,249
-439,023
| -31% | -$3.19M |
2021 Q2
2 quarters
|
|
15
Integer Holdings
ITGR
$4.31B
| $6.67M | 2.01% |
77,881
+22,990
| +42% | +$2.01M |
2021 Q2
2 quarters
|
|
|
RCOR
16
DELISTED
Renovacor, Inc.
RCOR
| $5.67M | 1.71% |
735,908
-415
| -0.1% | -$3.43K |
2021 Q1
3 quarters
|
|
17
Organon & Co
OGN
$3.62B
| $5.41M | 1.63% |
+177,659
| New | +$5.79M |
2021 Q4
0 quarters
|
|
|
PRDS
18
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $5.12M | 1.54% |
+312,438
| New | +$3.63M |
2021 Q4
0 quarters
|
|
|
ALBO
19
DELISTED
Albireo Pharma Inc
ALBO
| $4.98M | 1.5% |
213,913
+420
| +0.2% | +$11.2K |
2020 Q3
5 quarters
|
|
|
ISO
20
DELISTED
IsoPlexis Corporation Common Stock
ISO
| $4.55M | 1.37% |
+495,012
| New | +$5.49M |
2021 Q4
0 quarters
|
|
21
Sanofi
SNY
$95.7B
| $4.42M | 1.33% |
+88,249
| New | +$4.36M |
2021 Q4
0 quarters
|
|
22
Mirum Pharmaceuticals
MIRM
$5.15B
| $4.31M | 1.3% |
270,314
+21,336
| +9% | +$332K |
2020 Q4
4 quarters
|
|
|
ARNA
23
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.94M | 1.19% |
42,379
+20,641
| +95% | +$1.36M |
2019 Q3
9 quarters
|
|
|
VAPO
24
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $3.73M | 1.12% |
+22,502
| New | +$3.9M |
2021 Q4
0 quarters
|
|
25
DELISTED
Kezar Life Sciences
KZR
| $3.56M | 1.07% |
+21,325
| New | +$2.41M |
2021 Q4
0 quarters
|
|
Similar funds
EFL
V
MAM
RCM
AMG
VV
VCP
EHI
Sio Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Sio Capital Management held 84 positions worth $332M, up 5.7% from $314M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Sio Capital Management deployed $32.5M of net new capital in Q4 2021, opening 23 new positions and adding to 13 existing holdings. Its largest new stake was Medicus Sciences Acquisition Corp. Class A Ordinary Share: 2,323,000 shares worth $22.6M.
By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 88% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was Universal Health Services, an estimated $12.8M trimmed.
- Sio Capital Management's largest Q4 2021 buy was Medicus Sciences Acquisition Corp. Class A Ordinary Share: 2,323,000 shares worth $22.6M.
- Sio Capital Management added most to Cardinal Health in Q4 2021, an estimated $9.51M increase.
- Sio Capital Management's biggest Q4 2021 reduction was Universal Health Services, cutting an estimated $12.8M.
- Sio Capital Management fully exited Soliton, Inc. in Q4 2021, selling an estimated $16.8M.
- Sio Capital Management's ten largest holdings make up 52% of its $332M portfolio in Q4 2021.
- Sio Capital Management opened 23 new positions and closed 14 in Q4 2021.
- Sio Capital Management's portfolio value rose 5.7% quarter-over-quarter to $332M.
Based on Sio Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.